Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Biogen 2.736, Baxter International 2.96.
Biogen vs Baxter International: Revenue Comparison
Biogen (BIIB) and Baxter International (BAX) are peers in Healthcare. Biogen reported revenue of $2.7B as of Q2 2026, compared with $3.0B for Baxter International. Baxter International leads on revenue.
Biogen's gross margin is 56.9% versus 34.9% for Baxter International. Biogen's net margin is 3.6% versus 4.3% for Baxter International.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Biogen, Baxter International.| Metric | Biogen | Baxter International |
|---|---|---|
| Market Cap | - | - |
| Revenue | $2.74B | $2.96B |
| Cost of Revenue | $1.18B | $1.93B |
| Gross Profit | $1.56B | $1.03B |
| Operating Income | $318.00M | $217.00M |
| Net Income | $98.00M | $126.00M |
| R&D Expense | $496.00M | $129.00M |
| Earnings Per Share | $0.66 | $0.24 |
| Gross Margin | 56.9% | 34.9% |
| Operating Margin | 11.6% | 7.3% |
| Net Profit Margin | 3.6% | 4.3% |
| Free Cash Flow | $490.00M | $32.00M |
| Cumulative Free Cash Flow | $47.88B | $35.82B |
| Operating Cash Flow | $449.00M | $285.00M |
| Cash & Equivalents | $1.28B | $2.15B |